Tags

Type your tag names separated by a space and hit enter

The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.
PLoS One. 2009; 4(1):e4191.Plos

Abstract

BACKGROUND

Adjuvant treatment with radioactive iodine (RAI) is often considered in the treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of thyroid cancer survivors on the diagnosis of WDTC, adjuvant radioactive iodine (RAI) treatment, and decision-making related to RAI treatment. Participants provided recommendations for healthcare providers on counseling future patients on adjuvant RAI treatment.

METHODS

We conducted three focus group sessions, including WDTC survivors recruited from two Canadian academic hospitals. Participants had a prior history of WDTC that was completely resected at primary surgery and had been offered adjuvant RAI treatment. Open-ended questions were used to generate discussion in the groups. Saturation of major themes was achieved among the groups.

FINDINGS

There were 16 participants in the study, twelve of whom were women (75%). All but one participant had received RAI treatment (94%). Participants reported that a thyroid cancer diagnosis was life-changing, resulting in feelings of fear and uncertainty. Some participants felt dismissed as not having a serious disease. Some participants reported receiving conflicting messages from healthcare providers on the appropriateness of adjuvant RAI treatment or insufficient information. If RAI-related side effects occurred, their presence was not legitimized by some healthcare providers.

CONCLUSIONS

The diagnosis and treatment of thyroid cancer significantly impacts the lives of survivors. Fear and uncertainty related to a cancer diagnosis, feelings of the diagnosis being dismissed as not serious, conflicting messages about adjuvant RAI treatment, and treatment-related side effects, have been raised as important concerns by thyroid cancer survivors.

Authors+Show Affiliations

Division of Endocrinology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. sawkaam@yahoo.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

19142227

Citation

Sawka, Anna M., et al. "The Impact of Thyroid Cancer and Post-surgical Radioactive Iodine Treatment On the Lives of Thyroid Cancer Survivors: a Qualitative Study." PloS One, vol. 4, no. 1, 2009, pp. e4191.
Sawka AM, Goldstein DP, Brierley JD, et al. The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PLoS One. 2009;4(1):e4191.
Sawka, A. M., Goldstein, D. P., Brierley, J. D., Tsang, R. W., Rotstein, L., Ezzat, S., Straus, S., George, S. R., Abbey, S., Rodin, G., O'Brien, M. A., Gafni, A., Thabane, L., Goguen, J., Naeem, A., & Magalhaes, L. (2009). The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. PloS One, 4(1), e4191. https://doi.org/10.1371/journal.pone.0004191
Sawka AM, et al. The Impact of Thyroid Cancer and Post-surgical Radioactive Iodine Treatment On the Lives of Thyroid Cancer Survivors: a Qualitative Study. PLoS One. 2009;4(1):e4191. PubMed PMID: 19142227.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study. AU - Sawka,Anna M, AU - Goldstein,David P, AU - Brierley,James D, AU - Tsang,Richard W, AU - Rotstein,Lorne, AU - Ezzat,Shereen, AU - Straus,Sharon, AU - George,Susan R, AU - Abbey,Susan, AU - Rodin,Gary, AU - O'Brien,Mary Ann, AU - Gafni,Amiram, AU - Thabane,Lehana, AU - Goguen,Jeannette, AU - Naeem,Asima, AU - Magalhaes,Lilian, Y1 - 2009/01/14/ PY - 2008/08/01/received PY - 2008/12/10/accepted PY - 2009/1/15/entrez PY - 2009/1/15/pubmed PY - 2009/3/24/medline SP - e4191 EP - e4191 JF - PloS one JO - PLoS One VL - 4 IS - 1 N2 - BACKGROUND: Adjuvant treatment with radioactive iodine (RAI) is often considered in the treatment of well-differentiated thyroid carcinoma (WDTC). We explored the recollections of thyroid cancer survivors on the diagnosis of WDTC, adjuvant radioactive iodine (RAI) treatment, and decision-making related to RAI treatment. Participants provided recommendations for healthcare providers on counseling future patients on adjuvant RAI treatment. METHODS: We conducted three focus group sessions, including WDTC survivors recruited from two Canadian academic hospitals. Participants had a prior history of WDTC that was completely resected at primary surgery and had been offered adjuvant RAI treatment. Open-ended questions were used to generate discussion in the groups. Saturation of major themes was achieved among the groups. FINDINGS: There were 16 participants in the study, twelve of whom were women (75%). All but one participant had received RAI treatment (94%). Participants reported that a thyroid cancer diagnosis was life-changing, resulting in feelings of fear and uncertainty. Some participants felt dismissed as not having a serious disease. Some participants reported receiving conflicting messages from healthcare providers on the appropriateness of adjuvant RAI treatment or insufficient information. If RAI-related side effects occurred, their presence was not legitimized by some healthcare providers. CONCLUSIONS: The diagnosis and treatment of thyroid cancer significantly impacts the lives of survivors. Fear and uncertainty related to a cancer diagnosis, feelings of the diagnosis being dismissed as not serious, conflicting messages about adjuvant RAI treatment, and treatment-related side effects, have been raised as important concerns by thyroid cancer survivors. SN - 1932-6203 UR - https://www.unboundmedicine.com/medline/citation/19142227/The_impact_of_thyroid_cancer_and_post_surgical_radioactive_iodine_treatment_on_the_lives_of_thyroid_cancer_survivors:_a_qualitative_study_ L2 - https://dx.plos.org/10.1371/journal.pone.0004191 DB - PRIME DP - Unbound Medicine ER -